Epigral has incorporated a wholly owned subsidiary, Epigral Advanced Materials Limited, on July 7, 2026, to expand its manufacturing capabilities in the chemicals sector. The new entity has been established with a paid-up capital of ₹1,00,000, comprising 10,000 equity shares of ₹10 each. This strategic move aims to strengthen the company's presence in the advanced chemicals segment within India.

Subsidiary Details

Epigral Advanced Materials Limited is registered as a wholly owned subsidiary of Epigral Limited, making it a related party. The incorporation follows Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The subsidiary's primary objective is the manufacturing of chemicals, aligning with Epigral's broader business focus.

The consideration for the subscription was settled in cash. No specific governmental or regulatory approvals were required for the incorporation, as indicated in the filing submitted to the National Stock Exchange of India Limited and BSE Limited.

The promoter group of Epigral Limited has confirmed that no shares held by them were encumbered during the financial year ended March 31, 2026. This declaration was submitted to the National Stock Exchange of India Limited and BSE Limited, providing assurance to investors regarding the status of promoter holdings.

The disclosure was made pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The regulation requires promoters to inform the exchanges if they have pledged or created any charge on their shares. The confirmation indicates that the promoter group's shareholding remains free of such obligations for the reported period.

The declaration was signed by seven members of the promoter group on April 1, 2026. The signatories included Maulik Jayantibhai Patel, Kaushal Ashishbhai Soparkar, Jayantibhai Meghajibhai Patel, Ashishbhai Natawarlal Soparkar, Natwarlal Meghjiibhai Patel, Rameshbhai Meghjibhai Patel, and Anandbhai Ishwarbhai Patel. Each promoter confirmed the status on behalf of themselves and the broader promoter group.

Key Disclosures

The company has requested the exchanges to place the information on their records. Epigral Limited is headquartered at Epigral Tower, Corporate Road, Prahladnagar, Ahmedabad.